Cargando…
First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma—A Retrospective Study
Objectives: There is a lack of effective therapy for recurrent or metastatic salivary gland carcinoma. Androgen deprivation therapy has demonstrated efficacy in cases of salivary duct carcinoma (SDC) and high-grade adenocarcinoma not otherwise specified (NOS) that express androgen receptor. Material...
Autores principales: | Viscuse, Paul V., Price, Katharine A., Garcia, Joaquin J., Schembri-Wismayer, David J., Chintakuntlawar, Ashish V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688187/ https://www.ncbi.nlm.nih.gov/pubmed/31428578 http://dx.doi.org/10.3389/fonc.2019.00701 |
Ejemplares similares
-
Systemic therapy for recurrent or metastatic salivary gland malignancies
por: Chintakuntlawar, Ashish V., et al.
Publicado: (2016) -
Androgen Receptor Signaling in Salivary Gland Cancer
por: Dalin, Martin G., et al.
Publicado: (2017) -
Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature
por: You, Yongfei, et al.
Publicado: (2021) -
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
por: Cavalieri, Stefano, et al.
Publicado: (2023) -
Clinical Considerations for the Management of Androgen Indifferent Prostate Cancer
por: Berchuck, Jacob E., et al.
Publicado: (2021)